Page last updated: 2024-09-03

ym 022 and tetragastrin

ym 022 has been researched along with tetragastrin in 1 studies

Compound Research Comparison

Studies (ym 022)	Trials (ym 022)	Recent Studies (post-2010) (ym 022)	Studies (tetragastrin)	Trials (tetragastrin)	Recent Studies (post-2010) (tetragastrin)
65	1	8	544	72	32

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Brammer, N; Dunlop, J; Ennis, C; Evans, N	1

Other Studies

1 other study(ies) available for ym 022 and tetragastrin

Article	Year
YM022 [(R)-1-[2,3-dihydro-1-(2'-methylphenacyl)-2-oxo-5-phenyl-1H-1,4- benzodiazepin-3-yl]-3-(3-methylphenyl)urea]: an irreversible cholecystokinin type-B receptor antagonist. Biochemical pharmacology, 1997, Jul-01, Volume: 54, Issue:1 Topics: Animals; Benzodiazepines; Benzodiazepinones; Binding, Competitive; Calcium; CHO Cells; Cricetinae; Humans; Phenylurea Compounds; Receptor, Cholecystokinin B; Receptors, Cholecystokinin; Signal Transduction; Tetragastrin; Transfection	1997

Article

Year

YM022 [(R)-1-[2,3-dihydro-1-(2'-methylphenacyl)-2-oxo-5-phenyl-1H-1,4- benzodiazepin-3-yl]-3-(3-methylphenyl)urea]: an irreversible cholecystokinin type-B receptor antagonist.

Biochemical pharmacology, 1997, Jul-01, Volume: 54, Issue:1

Topics: Animals; Benzodiazepines; Benzodiazepinones; Binding, Competitive; Calcium; CHO Cells; Cricetinae; Humans; Phenylurea Compounds; Receptor, Cholecystokinin B; Receptors, Cholecystokinin; Signal Transduction; Tetragastrin; Transfection

1997